The committee will discuss a supplemental new drug application (sNDA) for MAKENA (hydroxyprogesterone caproate injection) by AMAG Pharmaceuticals.
Back to All Events
Earlier Event: October 16
Antimicrobial Drugs Advisory Committee
Later Event: October 30
Bone, Reproductive and Urologic Drugs Advisory Committee